Maria Paola Cassarani

Maria Paola Cassarani

Auto-generated profile, based on publicly available information

Maria Paola Cassarani

Centro Veterinario Oculistico Argo

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKatherine Stanbury
Katherine Stanbury
MCMaria Paola Cassarani
Maria Paola Cassarani
JBJoseph P. Boyle
Joseph P. Boyle
ESEllen Schofield
Ellen Schofield
BMBryan McLaughlin
Bryan McLaughlin
CMCathryn Mellersh
Cathryn Mellersh
GAPO syndrome is characterised by a core combination of phenotypes: g rowth retardation, a lopecia, p seudoanodontia and o cular atrophy, and to date has only been reported in humans. It is a rare autosomal recessive condition caused by pathogenic variants in the Anthrax Toxin Receptor 1 ( ANTXR1 ) gene. This study reports a canine form of the disease observed in a litter of Segugio Italiano dogs. Affected dogs, examined at 21 months old, presented with the core GAPO phenotype, short limbs, craniofacial abnormalities, alopecia, pseudoanodontia, and ocular abnormalities that included glaucoma. Whole genome sequence analysis of two affected puppies and the dam identified a nonsense variant c.505C > T in ANTXR1 which introduces an early stop codon in exon 7, predicted to truncate the protein by 395 amino acids. Comparative quantification of ANTXR1 gene expression in corneal, retinal and optic nerve tissues of a GAPO-affected dog were markedly reduced compared to control samples. Evaluation of protein expression through Western blot analysis using retinal and optic nerve tissue showed absence of ANTXR1 in the affected dog. Access to canine ocular tissues, rarely available in human GAPO patients, provides insight into tissue-specific effects of ANTXR1 loss. Our findings establish this canine disorder as a model of human GAPO syndrome and has facilitated the development of a DNA test that can identify carriers of the disease variant and prevent production of affected litters with this life limiting disease.